Translational Drug Development (TD2)
Kacey Champion is an accomplished accounting and operations professional with extensive experience in various managerial roles. Currently serving as Accounting Manager and System Administrator at Translational Drug Development (TD2) since July 2021, Kacey previously held positions such as Project Accountant and Operations Manager at Baghouse America from September 2019 to July 2021. Prior experience includes working as an Accounts Payable Specialist at Grand Canyon University from January 2016 to March 2019 and as Site Manager at Roers Property Management from June 2012 to December 2015. Kacey holds a Master of Science in Organizational Leadership and Entrepreneurship from Grand Canyon University (2017-2018) and a Bachelor's degree in Marketing from the same institution (2009-2013).
This person is not in any teams
Translational Drug Development (TD2)
Translational Drug Development (TD2) is an oncology-focused Contract Research Organization (CRO) that supports improved and accelerated development of medicines for life-threatening diseases. We help companies move their drugs through the critical stages of preclinical, regulatory and clinical trial processes. Our scientific depth, proactive problem solving, and strategic direction and advice increase the likelihood of positive outcomes that bring hope and a better quality of life to cancer patients and their families. TD2 was born from the Translational Genomics Research Institute (TGen) as a nonprofit in 2003. TGen’s deep scientific expertise and approach to interrogating the “omic” drivers of disease is at the heart of TD2’s heritage and has become the foundation upon which TD2 creates unique clinical strategies for its clients.